CDK4 and central nervous system cancer: Whilst several small sample clinical studies have indicated that the use of CDK4/6 inhibitors were well tolerated in adult and paediatric high-grade glioma, to the best of our knowledge, the combination with radiotherapy has not been explored clinically [13, 59, 62, 63].